

Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|6|1|103-124
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.6, Iss.1, 2006-03, pp. : 103-124
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




GAD-alum: balanced results in new-onset type 1 diabetes
Inpharma, Vol. 1, Iss. 1660, 2008-01 ,pp. :




By Lang Florian Görlach Agnes Vallon Volker
Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 11, 2009-11 ,pp. :